Regulators probe J&J's marketing of recalled hip implants

February 25, 2013 by Arezu Sarvestani

Federal investigators investigate Johnson & Johnson and its DePuy Orthopaedics subsidiary for possible violations in marketing the recalled ASR hip implants.

hip implant x-ray illustration

Federal investigators recently launched an additional inquiry into Johnson & Johnson (NYSE:JNJ) and its DePuy Orthopaedics subsidiary, taking a closer look at marketing practices surrounding a line of recalled metal-on-metal hips.

J&J confirmed in regulatory filings last week that the U.S. State Attorney's Office for the District of Massachusetts and the Civil Division of the U.S. Justice Dept. had made "informal requests" for information about the ASR XL Hip devices.

Initial requests were made in August 2012 and additional inquiries have been made since then, according to a regulatory filing.

Sign up to get our free newsletters delivered right to your inbox.

"The government is investigating whether any person or entity submitted or caused to be submitted false claims or false statements affecting federal health care programs in connection with the marketing and use of the ASR XL Hip device," J&J reported. "DePuy Orthopaedics, Inc., DePuy Synthes, and Johnson & Johnson Services, Inc. have voluntarily produced documents in response to the government's informal requests and are fully cooperating with the government's civil investigation."